Enliven Therapeutics, Inc. · NASDAQ:ELVN

Enliven Therapeutics, Inc. insider trades

Enliven Therapeutics, Inc.'s insiders made 0 buys and 45 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Oct 1, 2026Garland J. ScottSale13,000US$47Form 4
Sep 17, 2026Hohl BenjaminSale3,535US$50Form 4
Sep 17, 2026Hohl BenjaminSale2,194US$51Form 4
Sep 17, 2026Hohl BenjaminSale289US$51Form 4
Sep 17, 2026Collins Helen LouiseSale1,844US$51Form 4
Sep 17, 2026Collins Helen LouiseSale2,916US$50Form 4
Sep 17, 2026Collins Helen LouiseSale240US$51Form 4
Aug 17, 2026Hohl BenjaminSale4,630US$58Form 4
Aug 17, 2026Hohl BenjaminSale1,388US$59Form 4
Aug 17, 2026Collins Helen LouiseSale3,900US$58Form 4

Enliven Therapeutics, Inc. shareholders